Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Randomised, Multicentre Clinical Study to Investigate the Safety and Efficacy of Steroid Withdrawal With Tacrolimus, Mycophenolate Mofetil and Daclizumab Against Tacrolimus, Mycophenolate Mofetil and Steroids in Children After Kidney Transplantation

NCT00296348 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00296348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Randomised, Multicentre Clinical Study to Investigate the Safety and Efficacy of Steroid Withdrawal With Tacrolimus, Mycophenolate Mofetil and Daclizumab Against Tacrolimus, Mycophenolate Mofetil and Steroids in Children After Kidney Transplantation
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2005
Completion date
February 29, 2008
Enrollment
198 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation